Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam

Recruiting now · Not applicable

Conditions studied: Flumazenil Adverse Reaction, Remimazolam, Hip Joint, Elderly Patients

In brief

Remimazolam is a medication that has the advantage of a short half-life and reversibility with flumazenil. In clinical situations, the use of flumazenil for the reversal of sedation is common, but there is no precise indication for its administration. In this study, we aim to investigate the necessity of routine flumazenil use after administering remimazolam for intravenous anesthesia.

Key facts

Study ID
NCT05939674
Run by
Pusan National University Yangsan Hospital
People needed
24
Starts
2023-09-19
Expected to finish
2026-06-01
Last updated by the study team
2025-09-12

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.